Repare Therapeutics Inc. (RPTX)
1.16
0.01 (0.87%)
At close: Jan 30, 2025, 12:44 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Revenue | 51.13M | 131.83M | 7.60M | 135.00K | n/a | n/a | n/a |
| Cost of Revenue | 131.20M | 4.18M | 3.34M | 1.79M | 968.00K | 407.00K | 102.00K |
| Gross Profit | -80.07M | 127.65M | 4.26M | -1.65M | -968.00K | -407.00K | -102.00K |
| Operating Income | -116.22M | -19.80M | -108.66M | -54.30M | -26.38M | -12.82M | -6.17M |
| Interest Income | 13.33M | 5.63M | 259.00K | 240.00K | n/a | n/a | n/a |
| Pretax Income | -103.18M | -13.90M | -108.59M | -54.74M | -27.02M | -14.25M | -7.80M |
| Net Income | -93.80M | -29.05M | -106.91M | -53.42M | -27.22M | -14.28M | -7.80M |
| Selling & General & Admin | 33.76M | 32.56M | 26.21M | 14.35M | 5.38M | 2.91M | 1.77M |
| Research & Development | 133.59M | 119.07M | 90.05M | 40.09M | 21.00M | 9.91M | 4.40M |
| Other Expenses | n/a | -43.00K | -41.00K | -16.00K | -1.36M | -1.14M | -1.47M |
| Operating Expenses | 167.36M | 151.63M | 116.26M | 54.44M | 26.38M | 12.82M | 6.17M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 167.36M | 151.63M | 116.26M | 54.44M | 26.38M | 12.82M | 6.17M |
| Income Tax | -9.38M | 15.15M | -1.68M | -1.32M | 195.00K | 35.00K | 147.00K |
| Shares Outstanding (Basic) | 42.09M | 41.92M | 37.82M | 36.90M | 36.67M | 15.79M | 15.79M |
| Shares Outstanding (Diluted) | 42.09M | 41.92M | 37.82M | 36.90M | 36.67M | 15.79M | 15.79M |
| EPS (Basic) | -2.23 | -0.69 | -2.83 | -1.45 | -0.74 | -0.9 | -0.49 |
| EPS (Diluted) | -2.23 | -0.69 | -2.83 | -1.45 | -0.74 | -0.9 | -0.49 |
| EBITDA | -114.27M | -17.82M | -107.19M | -53.41M | -25.49M | -13.51M | -7.53M |
| Depreciation & Amortization | 1.95M | 4.18M | 3.34M | 1.79M | 968.00K | 407.00K | 102.00K |